Li JB, Jiang J, Xue L, Zhao S, Liu HQ. Clinical efficacy of Baijin pills in the treatment of generalized tonic-clonic seizure epilepsy with cognitive impairment. World J Psychiatry 2024; 14(6): 938-944 [PMID: 38984341 DOI: 10.5498/wjp.v14.i6.938]
Corresponding Author of This Article
Hong-Quan Liu, MD, Chief Doctor, Chief Physician, Department of Neurology, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, No. 100 Cross Street, Hongshan Road, Nanjing 210000, Jiangsu Province, China. hongquanliu0305@163.com
Research Domain of This Article
Psychology, Development
Article-Type of This Article
Prospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatry. Jun 19, 2024; 14(6): 938-944 Published online Jun 19, 2024. doi: 10.5498/wjp.v14.i6.938
Table 1 Characteristics of patients
Experimental group
Control group
Sample size
40
40
Female
20
18
Age (yr)
40.92 ± 13.51
42.37 ± 12.3
Clinical course
5.65 ± 2.34
5.91 ± 1.62
Education background
Bachelor's degree or above
8
10
Table 2 The frequency, duration, and difference of seizures before and after treatment were compared between the two groups
Group
Sample size
Period
Attack frequency/6 months
Seizure duration (min/time)
Experiment group
40
Before treatment
12.60 ± 6.00
3.55 ± 1.75
After treatment
8.77 ± 5.75
1.62 ± 1.55
The difference before and after treatment
3.82 ± 1.53
2.49 ± 0.83
Control group
40
Before treatment
12.98 ± 6.26
3.75 ± 1.69
After treatment
9.45 ± 5.99
2.12 ± 1.81
The difference before and after treatment
2.72 ± 2.18
1.48 ± 0.75
Table 3 Comparison of Montreal Cognitive Assessment Scale scores before and after treatment between the two groups
Group
Experiment group (n = 40)
Control group (n = 40)
Before treatment
After treatment
Before treatment
After treatment
MoCA total score 30
18.25 ± 2.34
20.43 ± 2.65
17.65 ± 2.16
16.53 ± 1.98
Memory ability 5
2.75 ± 0.81
3.15 ± 0.96
2.64 ± 0.79
2.40 ± 0.73
Verbal fluency 3
2.13 ± 0.78
2.52 ± 0.92
2.06 ± 0.77
1.97 ± 0.72
Visuospatial execution ability 5
2.98 ± 0.59
3.27 ± 0.70
2.87 ± 0.61
2.71 ± 0.58
Naming capability3
2.10 ± 0.81
2.30 ± 0.85
2.07 ± 0.79
1.94 ± 0.77
Attention and calculation ability 6
3.05 ± 0.78
3.42 ± 0.84
3.01 ± 0.76
2.74 ± 0.72
Orientation ability 6
4.02 ± 0.89
4.45 ± 0.93
3.94 ± 0.85
3.79 ± 0.81
Ability of abstraction and generalization 2
1.09 ± 0.45
1.31 ± 0.56
1.04 ± 0.49
0.95 ± 0.42
Table 4 The Quality of Life Rating Scale (QOLIE-31) score before and after treatment and the difference between the two groups
Group
Sample size
Period
QOLIE-31 score
Experiment group
40
Before treatment
43.32 ± 7.45
After treatment
51.46 ± 8.12
The difference before and after treatment
9.44 ± 5.23
Control group
40
Before treatment
44.56 ± 6.92
After treatment
48.42 ± 7.83
The difference before and after treatment
4.26 ± 4.78
Citation: Li JB, Jiang J, Xue L, Zhao S, Liu HQ. Clinical efficacy of Baijin pills in the treatment of generalized tonic-clonic seizure epilepsy with cognitive impairment. World J Psychiatry 2024; 14(6): 938-944